Involvement of AVP and V1a receptors in hypercortisolism has been confirmed in a patient with an AVP-sensitive BMAH in whom oral administration of a non-peptidic V1a antagonist significantly decreased urinary cortisol level (82). This evidence concerns the gene AVP and adrenal gland hyperfunction.